Open AccessHigh‐grade myofibroblastic sarcoma of the pleura: A case report and literature review
Author(s) -
Zhao Ruizhi,
Wang Jianyang,
Zhang Hongtu,
Chi Yihebali,
Bi Nan
Publication year - 2020
Publication title -
thoracic cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.823
H-Index - 28
eISSN - 1759-7714
pISSN - 1759-7706
DOI - 10.1111/1759-7714.13613
Subject(s) - medicine , ifosfamide , sarcoma , epirubicin , chemotherapy , radiation therapy , biopsy , parietal pleura , undifferentiated pleomorphic sarcoma , pathological , immunohistochemistry , pathology , radiology , surgery , lung , cyclophosphamide , cisplatin , soft tissue sarcoma
High‐grade myofibroblastic sarcoma (HGMS) is a rare cancer that has high recurrence and metastatic rates. Here, we report the first case of HGMS originating from the pleura. Based on the findings of pleural biopsy, pathological examination and immunohistochemical staining, grade III myofibroblastic sarcoma (MS) was diagnosed. The patient underwent eight cycles of chemotherapy (epirubicin and ifosfamide), followed by radiotherapy. As of May 2020, the patient had been followed for six months and no tumor progression had occurred. Key points This is the first report of high‐grade myofibroblastic sarcoma originating from the pleura. The patient was treated via nonsurgical strategies, including chemotherapy and radiotherapy.